AdvertisementAn Early, Unreleased Study Suggested Avandia Couldn't Beat ActosJuly 13, 2010Scott HensleyfacebookEmailNew allegations about GlaxoSmithKline's handling of safety questions about Avandia have surfaced. (Getty Images)